CENTRAL LUZON DOCTORS’ HOSPITAL

EDUCATIONAL INSTITUTION, INC

Romulo Highway, San Pablo, Tarlac City
Tel No. (045) 982-5019/ 982-5052/ 982-0264 Fax No. (045) 982-0780/982-2757

DEPARTMENT OF NURSING
DRUG STUDY
NAME CLASSIFICATION INDICATION/S CONTRAINDICATION/S SIDEEFFECTS ADVERSE EFFECTS NURSING RESPONSIBILITIES

Generic: PHARMACOTHER Mupirocin Hypersensitivity to this CNS: Headache Superinfection may Assess:
Mupirocin APEUTIC: (Bactroban) 2% product Precautions: Open result in bacterial,
EENT: Burning, • Allergic reaction: assess for
Antibacterial. Ointment is wounds, burns, severe fungal infections, esp.
pharyngitis, hypersensitivity; product
Brand: indicated for the kidney disease, children, with prolonged,
CLINICAL: Topical rhinitis (nasal) may need to be
Bactroban topical treatment pregnancy, breastfeeding repeated therapy.
antibiotic. discontinued
of primary and GI: Taste
• Infection: assess for
secondary change, nausea
Route: Topical number of lesions, severity
bacterial skin INTEG: in impetigo, other skin
infections. Burning, rash, disorders
Primary skin pruritus
Evaluate:
infections:
Impetigo, • Monitor healing of skin
folliculitis, lesions. In event of skin
furunculosis and reaction, stop applications,
ecthyma. cleanse area gently, notify
physician.
Secondary • Decreased lesions in
infections: impetigo, other skin
Infected disorders.
dermatoses e.g.,
infected eczema. Patient/family teaching
Infected traumatic • For external use only.
lesions e.g., • Not to use skin products
abrasions, insect near the eyes, nose, or
bites. mouth.
• To wash hands before and
after use and to wash
 affected area and gently pat
dry.
• Explain precautions to
avoid spread of infection;
teach how to apply
medication.( to apply a thin
film to the cleansed
affected area; to cover
treated areas with gauze
dressing if desired)
• Report skin reactions,
irritation.
• Report if no improvement
is noted in 3–5 days.

ADVERSE
NAME CLASSIFICATION INDICATION/S CONTRAINDICATION/S SIDEEFFECTS NURSING RESPONSIBILITIES
EFFECTS
 Func. class.: Treatment of Pregnancy 3rd trimester; Frequent: Diarrhea, Increased risk of Assessment:
Nonsteroidal acute pain, hypersensitivity to dyspepsia, cardiovascular
Generic: Celecoxib • Assess onset, type,
antiinflammatory, primary salicylates, iodides, other headache, upper events (MI, CVA), location, duration of
Brand: Celebrex antirheumatic dysmenorrhea. respiratory tract serious, potentially
NSAIDs, sulfonamides; pain/inflammation.
Dose: 200mg Relief of infection. life threatening GI
Chem. class.: COX- for perioperative pain in • Inspect appearance of
signs/symptoms Occasiona: bleeding.
Route: PO 2 inhibitor CABG affected joints for
associated with Abdominal pain, immobility, deformity, skin
ankylosing flatulence, nausea, condition. Assess for
spondylitis. back pain, allergy to sulfa, aspirin, or
peripheral edema, NSAIDs (contraindicated).
dizziness, insomnia,
rash. Intervention/evaluation
• Assess for therapeutic
response: pain relief;
decreased stiffness,
swelling, reduced joint
tenderness; improved
strength.
• Observe for bleeding,
bruising, weight gain.
Patient/family teaching
• If GI upset occurs, take
with food.
• Avoid aspirin, alcohol
(increases risk of GI
bleeding).
• Immediately report chest
pain, jaw pain, sweating,
confusion, difficulty
speaking, one-sided
weakness (may indicate
heart attack or stroke).
NAME CLASSIFICATION INDICATION/S CONTRAINDICATION/S SIDEEFFECTS ADVERSE EFFECTS NURSING RESPONSIBILITIES

Topical: Relief of Hypersensitivity to Frequent: Overdose may cause Assessment:

PHARMACOTHER inflammatory and betamethasone. Systemic: systemic
Generic: • Question for
APEUTIC: pruritic IM administration in Increased hypercorticism, adrenal
Betamethasone hypersensitivity to any
Adrenocorticosteroid dermatomes. idiopathic appetite, suppression. corticosteroid, sulfite.
Brand: Betaderm . thrombocytopenia abdominal • Obtain baseline values for
Dose: 3mg/ml purpura. distention,
CLINICAL: Anti- height, weight, B/P, serum
Cautions: nervousness,
Route: Topical inflammatory, glucose, electrolytes.
immunosuppressant. Hypothyroidism, insomnia, false • Obtain baseline results of
hepatic/renal impairment, sense of well- initial tests (tuberculosis
cardiovascular disease, being. [TB] skin test, X-rays,
diabetes, glaucoma, Topical: EKG).
cataracts, myasthenia Burning,
gravis. Intervention/evaluation
stinging,
pruritus. • Monitor B/P, blood
glucose, electrolytes.
Occasional: Apply topical preparation
Systemic: sparingly. Do not use on
Dizziness, facial broken skin or in areas of
flushing,
infection. Do not apply to
diaphoresis, wet skin, face, inguinal
decreased or areas.
blurred vision,
mood swings. Patient/family teaching
• Take with food, milk.
• Take single daily dose in
the morning.
• Do not stop abruptly.
• Apply topical preparations
in a thin layer.
• Do not receive smallpox
vaccination during or
immediately after therapy.